Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy
Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy
复制标题
DOI:
10.1161/circulationaha.107.710434
复制
发表时间:
2008-01-29
期刊:
影响因子:
37.8
通讯作者:
Otsu, Kinya
中科院分区:
文献类型:
--
作者:
Taniike, Masayuki;Yamaguchi, Osamu;Otsu, Kinya
Background - Mechanical stress on the heart can lead to crucially different outcomes. Physiological stimuli such as exercise cause adaptive cardiac hypertrophy, characterized by a normal cardiac structure and normal or enhanced cardiac function. Pathological stimuli such as hypertension and aortic valvular stenosis cause maladaptive cardiac remodeling and ultimately heart failure. Apoptosis signal-regulating kinase 1 (ASK1) is known to be involved in pathological cardiac remodeling, but it has not been determined whether ASK1 pathways coordinate the signaling cascade leading to physiological type cardiac growth.Methods and Results - To evaluate the role of ASK1 in the physiological form of cardiac growth, mice lacking ASK1 (ASK1(-/-)) were exercised by swimming for 4 weeks. ASK1(-/-) mice showed exaggerated growth of the heart accompanied by typical characteristics of physiological hypertrophy. Their swimming-induced activation of Akt, a key molecule in the signaling cascade of physiological hypertrophy, increased more than that seen in wild-type controls. The activation of p38, a downstream kinase of ASK1, was suppressed selectively in the swimming-exercised ASK1(-/-) mice. Furthermore, the inhibition of ASK1 or p38 activity enhanced insulin-like growth factor 1-induced protein synthesis in rat neonatal ventricular cardiomyocytes, and the treatment with a specific inhibitor of p38 resulted in enhancement of Akt activation and suppression of protein phosphatase 2A activation. The cardiac-specific p38 alpha-deficient mice developed an exacerbated form of cardiac hypertrophy in response to swimming exercise.Conclusions - These results indicate that the ASK1/p38 signaling pathway negatively regulates physiological hypertrophy.